MicroRNA-375: potential cancer suppressor and therapeutic drug.
Jiahui WeiYiran LuRuiqing WangXiangzhu XuQing LiuSong HeHuihao PanXinmiao LiuBao YuanYu DingJiabao ZhangPublished in: Bioscience reports (2022)
MiR-375 is a conserved noncoding RNA that is known to be involved in tumor cell proliferation, migration, and drug resistance. Previous studies have shown that miR-375 affects the epithelial-mesenchymal transition (EMT) of human tumor cells via some key transcription factors, such as Yes-associated protein 1 (YAP1), Specificity protein 1 (SP1) and signaling pathways (Wnt signaling pathway, nuclear factor κB (NF-κB) pathway and transforming growth factor β (TGF-β) signaling pathway) and is vital for the development of cancer. Additionally, recent studies have identified microRNA (miRNA) delivery system carriers for improved in vivo transportation of miR-375 to specific sites. Here, we discussed the role of miR-375 in different types of cancers, as well as molecular mechanisms, and analyzed the potential of miR-375 as a molecular biomarker and therapeutic target to improve the efficiency of clinical diagnosis of cancer.
Keyphrases
- cell proliferation
- epithelial mesenchymal transition
- signaling pathway
- transforming growth factor
- pi k akt
- long non coding rna
- nuclear factor
- papillary thyroid
- long noncoding rna
- cell cycle
- transcription factor
- squamous cell
- induced apoptosis
- stem cells
- toll like receptor
- childhood cancer
- squamous cell carcinoma
- oxidative stress
- young adults
- small molecule
- risk assessment
- immune response